Literature DB >> 33460469

Keratinocytes: innate immune cells in atopic dermatitis.

P Chieosilapatham1, C Kiatsurayanon2, Y Umehara3, J V Trujillo-Paez3, G Peng3, H Yue3, L T H Nguyen3, F Niyonsaba3,4.   

Abstract

The skin is a unique immune organ that constitutes a complex network of physical, chemical and microbiological barriers against external insults. Keratinocytes are the most abundant cell type in the epidermis. These cells form the physical skin barrier and represent the first line of the host defense system by sensing pathogens via innate immune receptors, initiating anti-microbial responses and producing various cytokines, chemokines and anti-microbial peptides, which are important events in immunity. A damaged epidermal barrier in atopic dermatitis allows the penetration of potential allergens and pathogens to activate keratinocytes. Among the dysregulation of immune responses in atopic dermatitis, activated keratinocytes play a role in several biological processes that contribute to the pathogenesis of atopic dermatitis. In this review, we summarize the current understanding of the innate immune functions of keratinocytes in the pathogenesis of atopic dermatitis, with a special emphasis on skin-derived anti-microbial peptides and atopic dermatitis-related cytokines and chemokines in keratinocytes. An improved understanding of the innate immunity mediated by keratinocytes can provide helpful insight into the pathophysiological processes of atopic dermatitis and support new therapeutic efforts.
© 2021 British Society for Immunology.

Entities:  

Keywords:  anti-microbial peptide; atopic dermatitis; chemokine; cytokine; innate immunity; keratinocyte

Mesh:

Substances:

Year:  2021        PMID: 33460469      PMCID: PMC8119845          DOI: 10.1111/cei.13575

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  102 in total

1.  IL-33 down-regulates filaggrin expression by inducing STAT3 and ERK phosphorylation in human keratinocytes.

Authors:  Woo-In Ryu; Hana Lee; Hyun Cheol Bae; Hwa Jung Ryu; Sang Wook Son
Journal:  J Dermatol Sci       Date:  2016-01-29       Impact factor: 4.563

2.  IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.

Authors:  Mark Peric; Sarah Koglin; Song-Min Kim; Shin Morizane; Robert Besch; Jörg C Prinz; Thomas Ruzicka; Richard L Gallo; Jürgen Schauber
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics.

Authors:  Yik Weng Yew; Jacob P Thyssen; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2018-10-01       Impact factor: 11.527

Review 4.  Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.

Authors:  Masutaka Furue; Takahito Chiba; Gaku Tsuji; Dugarmaa Ulzii; Makiko Kido-Nakahara; Takeshi Nakahara; Takafumi Kadono
Journal:  Allergol Int       Date:  2017-01-02       Impact factor: 5.836

5.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

6.  Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.

Authors:  Emma Guttman-Yassky; Patrick M Brunner; Avidan U Neumann; Saakshi Khattri; Ana B Pavel; Kunal Malik; Giselle K Singer; Danielle Baum; Patricia Gilleaudeau; Mary Sullivan-Whalen; Sharon Rose; Shelbi Jim On; Xuan Li; Judilyn Fuentes-Duculan; Yeriel Estrada; Sandra Garcet; Claudia Traidl-Hoffmann; James G Krueger; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2018-01-17       Impact factor: 11.527

7.  Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.

Authors:  Sanja Kezic; Gráinne M O'Regan; René Lutter; Ivone Jakasa; Ellen S Koster; Sean Saunders; Peter Caspers; Patrick M J H Kemperman; Gerwin J Puppels; Aileen Sandilands; Huijia Chen; Linda E Campbell; Karin Kroboth; Rosemarie Watson; Padraic G Fallon; W H Irwin McLean; Alan D Irvine
Journal:  J Allergy Clin Immunol       Date:  2012-02-08       Impact factor: 10.793

Review 8.  Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis.

Authors:  Bogusław Nedoszytko; Małgorzata Sokołowska-Wojdyło; Katarzyna Ruckemann-Dziurdzińska; Jadwiga Roszkiewicz; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2014-04-22       Impact factor: 1.837

9.  IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization.

Authors:  Juhan Yoon; Juan Manuel Leyva-Castillo; Guoxing Wang; Claire Galand; Michiko K Oyoshi; Lalit Kumar; Sabine Hoff; Rui He; Alexander Chervonsky; Joost J Oppenheim; Vijay K Kuchroo; Marcel R M van den Brink; Rene De Waal Malefyt; Philippe A Tessier; Robert Fuhlbrigge; Philip Rosenstiel; Cox Terhorst; George Murphy; Raif S Geha
Journal:  J Exp Med       Date:  2016-08-22       Impact factor: 14.307

Review 10.  NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis.

Authors:  Magdalena Ciążyńska; Igor A Bednarski; Karolina Wódz; Joanna Narbutt; Aleksandra Lesiak
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

View more
  13 in total

Review 1.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 2.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

Review 3.  Immunomodulatory Role of Staphylococcus aureus in Atopic Dermatitis.

Authors:  Ethan Jachen Chung; Chia-Hui Luo; Christina Li-Ping Thio; Ya-Jen Chang
Journal:  Pathogens       Date:  2022-03-30

Review 4.  Keratinocytes: An Enigmatic Factor in Atopic Dermatitis.

Authors:  Pamelika Das; Pappula Mounika; Manoj Limbraj Yellurkar; Vani Sai Prasanna; Sulogna Sarkar; Ravichandiran Velayutham; Somasundaram Arumugam
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

5.  Deacetylasperulosidic Acid Ameliorates Pruritus, Immune Imbalance, and Skin Barrier Dysfunction in 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis NC/Nga Mice.

Authors:  Jin-Su Oh; Geum-Su Seong; Yong-Deok Kim; Se-Young Choung
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

6.  Osthole Inhibits Expression of Genes Associated with Toll-like Receptor 2 Signaling Pathway in an Organotypic 3D Skin Model of Human Epidermis with Atopic Dermatitis.

Authors:  Natalia Karolina Kordulewska; Justyna Topa; Robert Stryiński; Beata Jarmołowska
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

Review 7.  Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies.

Authors:  Yanping Li; Ruoqiu Fu; Tingting Jiang; Dongyu Duan; Yuanlin Wu; Chen Li; Ziwei Li; Rui Ni; Li Li; Yao Liu
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 8.  Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets.

Authors:  Luca Fania; Gaia Moretta; Flaminia Antonelli; Enrico Scala; Damiano Abeni; Cristina Albanesi; Stefania Madonna
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

9.  Regulation of cell cycle and differentiation markers by pathogenic, non-pathogenic and opportunistic skin bacteria.

Authors:  Sidra Younis; Farah Deeba; Rida Fatima Saeed; Ramzi A Mothana; Riaz Ullah; Muhammad Faheem; Qamar Javed; Miroslav Blumenberg
Journal:  Saudi J Biol Sci       Date:  2021-11-02       Impact factor: 4.219

Review 10.  What's New in Topicals for Atopic Dermatitis?

Authors:  Elana Kleinman; Jennifer Laborada; Lauren Metterle; Lawrence F Eichenfield
Journal:  Am J Clin Dermatol       Date:  2022-09-01       Impact factor: 6.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.